DOSSIER · 13F Holders · Q2 2026
ANIP 2.25 09/01/29

ANI PHARMACEUTICALS INC

26 institutions still hold ANI PHARMACEUTICALS INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 00182CAC7·26 13F holders·last filed Jun 30, 2026
Market cap
13F value held
$310M
visible holders
Holders
26
filers reporting
Concentration
14.20%
CAMDEN ASSET MANAGEMENT L P /CA #1
top holder share
AI Holders Summary · Q2 2026

26 institutions reported ANIP 2.25 09/01/29 in Q2 2026. CAMDEN ASSET MANAGEMENT L P /CA leads at 14.2% of the visible book.

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
CAMDEN ASSET MANAGEMENT L P /CA
CIK 0000903944
$44M34.0M1.28%Q2 2026
02
Alberta Investment Management Corp
CIK 0001463559· Sovereign
$39M30.0M0.22%Q2 2026
03
Empyrean Capital Partners, LP
CIK 0001317195
$30M23.0M0.98%Q2 2026
04
HBK INVESTMENTS L P
CIK 0001011443
$26M20.1M0.26%Q2 2026
05
BlackRock, Inc.
CIK 0002012383
$20M15.1M0.00%Q2 2026
06
CITADEL ADVISORS LLC
CIK 0001423053
$19M15.0M0.00%Q4 2025
07
Point72 Asset Management, L.P.
CIK 0001603466
$19M15.0M0.02%Q1 2026
08
BOUSSARD & GAVAUDAN GESTION SAS
CIK 0001569001
$17M13K0.86%Q2 2026
09
Boussard & Gavaudan Investment Management LLP
CIK 0001614986
$16M13K1.55%Q1 2026
10
Nykredit A/S
CIK 0001847328
$16M12.0M0.05%Q2 2026
11
ABSOLUTE INVESTMENT ADVISERS, LLC
CIK 0001316187
$15M11.7M1.47%Q2 2026
12
JPMORGAN CHASE & CO
CIK 0000019617
$12M9.3M0.00%Q2 2026
13
Universal- Beteiligungs- und Servicegesellschaft mbH
CIK 0002057170
$11M8.3M0.02%Q2 2026
14
GOLDMAN SACHS GROUP INC
CIK 0000886982
$9M7.0M0.00%Q2 2026
15
GABELLI FUNDS LLC
CIK 0001081407
$7M5.0M0.04%Q2 2026
16
CITIGROUP INC
CIK 0000831001
$5M3.6M0.00%Q2 2026
17
FMR LLC
CIK 0000315066
$3M2.5M0.00%Q2 2026
18
Alken Asset Management Ltd
CIK 0001629996
$2M1K2.88%Q1 2026
19
BARCLAYS PLC
CIK 0000312069
$935K719K0.00%Q2 2026
20
Bank of New York Mellon Corp
CIK 0001390777
$845K650K0.00%Q2 2026
Page 1 of 2
6 more holders available. Log in →